Development and applications of mRNA treatment based on lipid nanoparticles
- 16 March 2023
- journal article
- review article
- Published by Elsevier in Biotechnology Advances
- Vol. 65, 108130
Abstract
No abstract availableKeywords
This publication has 203 references indexed in Scilit:
- Nonviral delivery of self-amplifying RNA vaccinesProceedings of the National Academy of Sciences, 2012
- Maximizing the Potency of siRNA Lipid Nanoparticles for Hepatic Gene Silencing In Vivo**Angewandte Chemie International Edition, 2012
- Mechanism of Neutralization by the Broadly Neutralizing HIV-1 Monoclonal Antibody VRC01Journal of Virology, 2011
- Highly Efficient Reprogramming to Pluripotency and Directed Differentiation of Human Cells with Synthetic Modified mRNACell Stem Cell, 2010
- Endocytosis of nanomedicinesJournal of Controlled Release, 2010
- Incorporation of pseudouridine into mRNA enhances translation by diminishing PKR activationNucleic Acids Research, 2010
- Lipid-mediated delivery of RNA is more efficient than delivery of DNA in non-dividing cellsInternational Journal of Pharmaceutics, 2010
- Lipid-like materials for low-dose, in vivo gene silencingProceedings of the National Academy of Sciences, 2010
- Development of Lipidoid–siRNA Formulations for Systemic Delivery to the LiverMolecular Therapy, 2009
- Incorporation of Pseudouridine Into mRNA Yields Superior Nonimmunogenic Vector With Increased Translational Capacity and Biological StabilityMolecular Therapy, 2008